Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J. Ellis, Mark A. Watson, Brian Andrew Van Tine et al.|Nature|2012Cited by 1k
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J. Ellis, Kelly K. Hunt, Vera J. Suman et al.|Journal of Clinical Oncology|2017Cited by 411
Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast CancersChristos Hatzis, W. Fraser Symmans, Hongxia Sun et al.|JNCI Journal of the National Cancer Institute|2011Cited by 124